>

MRD: Minimal Residual Disease in Hematooncology

Defining MRD

Minimal residual disease (MRD) is a term used in hematooncology to describe the presence of a small number of cancer cells that remain after treatment. These cells are typically detected through sensitive molecular methods like PCR.

Significance of MRD

The presence of MRD can indicate that the cancer has not been completely eradicated and could potentially lead to relapse. Monitoring MRD levels over time can help assess the effectiveness of treatment and guide further therapeutic decisions.